LEFT HEMICOLECTOMY FOR DOLICHOSIGMA IN CHILDREN: A COMPARATIVE ANALYSIS OF PERIOPERATIVE PARAMETERS AND COMPLICATION RATES
Main Article Content
Abstract
Introduction. Dolichosigma in children may be accompanied by chronic constipation, abdominal pain, and episodes of subobstruction; when stepwise conservative therapy is ineffective, surgical options are considered [1–3]. Aim. To compare key perioperative parameters and complication rates in children with dolichosigma undergoing left hemicolectomy. Materials and Methods. A comparative cohort study: control group (n=47) and study group (left hemicolectomy, n=38). Intraoperative parameters, time to functional recovery, length of hospital stay, and complications up to 12 months were assessed. Results. In the study group, operative time (113.4±13.8 vs 120.2±11.1 min) and blood loss (122.6±36.7 vs 163.8±52.0 mL) were reduced (p<0.05); return of bowel function, initiation of feeding, and mobilization were accelerated. The overall complication rate decreased from 63.8% (30/47) to 31.6% (12/38), χ²=8.743; p=0.004. Total length of hospital stay decreased from 22.1±3.2 to 15.1±5.2 days (p<0.001). Conclusion. Left hemicolectomy is associated with faster early recovery and reduced complication rates/length of hospital stay in children with dolichosigma.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1. Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations From ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. doi:10.1097/MPG.0000000000000266.
2. Kilgore AL, et al. Evaluation and management of pediatric refractory constipation: Recommendations from the NASPGHAN neurogastroenterology and motility committee. J Pediatr Gastroenterol Nutr. 2025. (Ahead of print/online).
3. Hyams JS, Di Lorenzo C, Saps M, et al. Childhood Functional Gastrointestinal Disorders: Child/Adolescent. In: Drossman DA, et al. Rome IV. Rome Foundation; 2016.
4. van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101(10):2401-2409. doi:10.1111/j.1572-0241.2006.00771.x.
5. Rajindrajith S, Devanarayana NM. Childhood constipation as an emerging public health problem. World J Gastroenterol. 2016;22(30):6864-6875. doi:10.3748/wjg.v22.i30.6864.
6. Pijpers MAM, Bongers MEJ, Benninga MA, Berger MY. Functional constipation in children: a systematic review on prognosis and predictive factors. J Pediatr Gastroenterol Nutr. 2010;50(3):256-268. doi:10.1097/MPG.0b013e3181afcdc3.
7. Benninga MA, Tabbers MM, van Rijn RR. How to use a plain abdominal radiograph in children with functional defecation disorders. Arch Dis Child Educ Pract Ed. 2016;101(4):214-220. doi:10.1136/archdischild-2015-309000.
8. U.S. Food and Drug Administration. FDA approves first treatment for pediatric functional constipation (linaclotide, LINZESS). 2023 Jun 12.
9. LINZESS (linaclotide) Prescribing Information / FDA Label. 2023.
10. Bolia R, Goel AD, Thapar N. Transanal irrigation in children with functional constipation: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2024. doi:10.1002/jpn3.12200.
11. Усмонов ТЮ, Тошпулатов Б. ИММУНОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ У ДЕТЕЙ С ХРОНИЧЕСКИМИ ЗАПОРАМИ, ВЛИЯНИЕ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ. International innovation and researches. 2025 Mar 28;2(2):109-11.
12. Тошпулатов ББ, Туланова ОС. СОВРЕМЕННЫЕ ПОДХОДЫ К ДИАГНОСТИКЕ И ЛЕЧЕНИЮ БОЛЕЗНИ ГИРШПРУНГА У ДЕТЕЙ. International innovation and researches. 2025 Mar 28;2(2):104-5.
13. Тошпулатов ББ, Урмонова РФ. БОЛЕЗНЬ ДОЛИХОСИГМА У ДЕТЕЙ. International innovation and researches. 2025 Mar 28;2(2):112-3.
14. Тошпулатов ББ, Кенжаева Г. ПРИЧИНА ВЫСОКОЙ СМЕРТНОСТИ ПРИ ВРОЖДЕННОЙ ДИАФРАГМАЛЬНОЙ ГРЫЖЕ И ПУТИ ЕЁ СНИЖЕНИЯ. International innovation and researches. 2025 Mar 28;2(2):106-8.
15. Тошпулатов ББ, Туланова О. НЕПРОИЗВОЛЬНОЕ ВЫДЕЛЕНИЕ ФЕКАЛИЙ ПОСЛЕ ОПЕРАЦИИ ПРИ БОЛЕЗНИ ГИРШПРУНГА, ПАТОГЕНЕЗ, ПРОФИЛАКТИКА И ЛЕЧЕНИЕ. International innovation and researches. 2025 Mar 28;2(2):114-8.